Possible WHO-Industry Conflict Of Interest On Pandemic Flu Under Investigation 07/06/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments Global health authorities have been guilty of “grave shortcomings” in transparency and accountability to the public good in their handling of the pandemic influenza outbreak says a new draft resolution from the intergovernmental Council of Europe. A related investigative report from the British Medical Journal found evidence of “declarable financial conflicts of interests” among the experts advising the World Health Organization. But WHO denies any wrongdoing.
Google May Face New Scrutiny For Privacy Violations In Switzerland 04/06/2010 by William New, Intellectual Property Watch Leave a Comment Legally speaking, there is “little doubt” that Google’s collection of WiFi data by its roving Street View vehicles violates the Swiss Data Protection Act, and the company is likely to come under new scrutiny in Switzerland possibly even resulting in “severe financial consequences,” a respected Swiss law firm has said.
China, India To Raise Concerns At WTO About “TRIPS-Plus” Measures, ACTA 03/06/2010 by William New, Intellectual Property Watch 3 Comments China and India, two increasingly potent players on the global economic stage, next week plan to voice concerns at the World Trade Organization about efforts by developed countries to push poorer trading partners beyond their WTO commitments on trade and intellectual property rights, so-called TRIPS-plus measures.
As WTO Reviews China, EU, US Criticise Its Policy On Innovation, IP Rights 03/06/2010 by Catherine Saez, Intellectual Property Watch Leave a Comment In the past two years, China has acted to improve the protection of intellectual property rights with a need for continuing effort, a World Trade Organization report has found, but the country came under criticism this week from key trading partners such as the United States and the European Union for not providing adequate enforcement and for self-serving innovation practices.
WIPO Proposals Would Open Cross-Border Access To Materials For Print Disabled 28/05/2010 by Kaitlin Mara for Intellectual Property Watch 3 Comments Negotiators trying to find a solution for the world’s print disabled, who have said copyright law is limiting their access to an already meagre supply of reading material in usable formats, began discussing a possible UN recommendation this week. But the print disabled and their strongest supporters have said such a recommendation – which would not be legally binding – would fall short of meeting their needs.
World Health Assembly Creates New Initiative For R&D Financing 21/05/2010 by Kaitlin Mara for Intellectual Property Watch 6 Comments World Health Organization members today took an important step closer to finding new ways to finance research and development into diseases afflicting developing countries.
New Resolution Gives Governments Control Of WHO Work On False Medicines 21/05/2010 by Kaitlin Mara for Intellectual Property Watch 5 Comments After an at times bitter week-long debate on the issue of fake and poor quality drugs, member states have decided they will lead the World Health Organization forward towards a resolution on the issue.
Latest Chair’s Draft Issued On Future Of WHO And IP, Innovation 20/05/2010 by William New, Intellectual Property Watch Leave a Comment The latest draft is now available from the Swiss chair overseeing a small side group at the World Health Assembly trying to work out how to take forward a landmark initiative within the UN agency on innovation and intellectual property rights. It shows that countries negotiating the WHO’s next step on the sensitive topic are leaning toward establishment of a new group with more government involvement this time.
New Draft Resolution On Counterfeits At WHO 20/05/2010 by Kaitlin Mara for Intellectual Property Watch and William New Leave a Comment A new conference paper has been submitted to the World Health Assembly committee addressing the World Health Organization work on counterfeit and substandard medicines. It offers a way forward on this week’s most controversial issue by involving governments directly in the activities through an intergovernmental working group.
WHO: No Evidence Of Misleading On Counterfeit Medicines 20/05/2010 by Kaitlin Mara for Intellectual Property Watch 3 Comments There is no evidence that the work of the World Health Organization has been misled or misled its members on the issue of fake or dangerous drugs, representatives of the UN organisation told journalists today. Nor is the WHO yet ready to drop use of the term ‘counterfeit’ to describe such medicines despite generic producing nations complaints about possible confusion over the term.